(Q36421762)

14 August 2017

Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposide (English)

1 reference

14 August 2017

1 reference

1 reference

de Jong RS

1

1 reference

14 August 2017

Mulder NH

2

1 reference

14 August 2017

Uges DR

3

1 reference

14 August 2017

Kaul S

4

1 reference

14 August 2017

Winograd B

5

1 reference

14 August 2017

Sleijfer DTh

6

1 reference

14 August 2017

Groen HJ

7

1 reference

14 August 2017

Willemse PH

8

1 reference

14 August 2017

van der Graaf WT

9

1 reference

14 August 2017

de Vries EG

10

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

British Journal of Cancer

14 August 2017

1 reference

14 August 2017

75

1 reference

14 August 2017

11

1 reference

14 August 2017

1660-1666

1 reference

Phase I study of etoposide phosphate (etopophos) as a 30-minute infusion on days 1, 3, and 5.

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223531

Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223531

Clinical activity of chronic oral etoposide in previously treated metastatic breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223531

Etoposide: twenty years later.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223531

Prediction of creatinine clearance from serum creatinine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223531

Prospective evaluation of a model for predicting etoposide plasma protein binding in cancer patients.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223531

The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223531

Pharmacokinetics of etoposide: correlation of pharmacokinetic parameters with clinical conditions

21 September 2018

1 reference

12 December 2020

Variable bioavailability following repeated oral doses of etoposide

1 reference

12 December 2020

The effect of dose on the bioavailability of oral etoposide: confirmation of a clinically relevant observation

1 reference

12 December 2020

Phase I clinical and pharmacokinetic study of oral etoposide phosphate

1 reference

12 December 2020

Phase II randomized study of cisplatin plus etoposide phosphate or etoposide in the treatment of small-cell lung cancer

1 reference

12 December 2020

A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer

1 reference

12 December 2020

Oral etoposide is active against platinum-resistant epithelial ovarian cancer

1 reference

12 December 2020

Pharmacokinetics of oral and intravenous melphalan during routine treatment of multiple myeloma

1 reference

12 December 2020

Probability distribution of multiple scattered light measured in total transmission

1 reference

12 December 2020

Etoposide protein binding in cancer patients

1 reference

12 December 2020

Phase I evaluation of a water-soluble etoposide prodrug, etoposide phosphate, given as a 5-minute infusion on days 1, 3, and 5 in patients with solid tumors

1 reference

12 December 2020

Variable bioavailability of oral mercaptopurine. Is maintenance chemotherapy in acute lymphoblastic leukemia being optimally delivered?

1 reference

12 December 2020

Bioavailability of cyclophosphamide from oral formulations

1 reference

12 December 2020

Altered protein binding of etoposide in patients with cancer

1 reference

12 December 2020

Relation of systemic exposure to unbound etoposide and hematologic toxicity

1 reference

12 December 2020

Bioavailability of low-dose oral etoposide

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1997.282

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

9184183

1 reference